316 related articles for article (PubMed ID: 29197371)
1. Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials.
Eggly S; Hamel LM; Heath E; Manning MA; Albrecht TL; Barton E; Wojda M; Foster T; Carducci M; Lansey D; Wang T; Abdallah R; Abrahamian N; Kim S; Senft N; Penner LA
BMC Cancer; 2017 Dec; 17(1):807. PubMed ID: 29197371
[TBL] [Abstract][Full Text] [Related]
2. Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study.
Eggly S; Senft N; Kim S; Heath EI; Jang H; Moore TF; Baidoun F; Manning MA; Penner LA; Albrecht TL; Carducci MA; Lansey D; Hamel LM
Cancer Med; 2023 Apr; 12(7):8604-8613. PubMed ID: 36540051
[TBL] [Abstract][Full Text] [Related]
3. A disparity of words: racial differences in oncologist-patient communication about clinical trials.
Eggly S; Barton E; Winckles A; Penner LA; Albrecht TL
Health Expect; 2015 Oct; 18(5):1316-26. PubMed ID: 23910630
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic and racial/ethnic differences in the discussion of cancer screening: "between-" versus "within-" physician differences.
Bao Y; Fox SA; Escarce JJ
Health Serv Res; 2007 Jun; 42(3 Pt 1):950-70. PubMed ID: 17489898
[TBL] [Abstract][Full Text] [Related]
5. Racial disparities in Black men with prostate cancer: A literature review.
Lillard JW; Moses KA; Mahal BA; George DJ
Cancer; 2022 Nov; 128(21):3787-3795. PubMed ID: 36066378
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Nonverbal synchrony as a behavioural marker of patient and physician race-related attitudes and a predictor of outcomes in oncology interactions: protocol for a secondary analysis of video-recorded cancer treatment discussions.
Hamel LM; Moulder R; Albrecht TL; Boker S; Eggly S; Penner LA
BMJ Open; 2018 Dec; 8(12):e023648. PubMed ID: 30518586
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
9. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials.
Braunstein JB; Sherber NS; Schulman SP; Ding EL; Powe NR
Medicine (Baltimore); 2008 Jan; 87(1):1-9. PubMed ID: 18204365
[TBL] [Abstract][Full Text] [Related]
10. Development of a Conceptual Framework for Understanding Shared Decision making Among African-American LGBT Patients and their Clinicians.
Peek ME; Lopez FY; Williams HS; Xu LJ; McNulty MC; Acree ME; Schneider JA
J Gen Intern Med; 2016 Jun; 31(6):677-87. PubMed ID: 27008649
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR
J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238
[TBL] [Abstract][Full Text] [Related]
12. Knowledge and attitudes regarding clinical trials and willingness to participate among prostate cancer patients.
Kaplan CP; Nápoles AM; Narine S; Gregorich S; Livaudais-Toman J; Nguyen T; Leykin Y; Roach M; Small EJ
Contemp Clin Trials; 2015 Nov; 45(Pt B):443-448. PubMed ID: 26435199
[TBL] [Abstract][Full Text] [Related]
13. Improving care for minorities: can quality improvement interventions improve care and outcomes for depressed minorities? Results of a randomized, controlled trial.
Miranda J; Duan N; Sherbourne C; Schoenbaum M; Lagomasino I; Jackson-Triche M; Wells KB
Health Serv Res; 2003 Apr; 38(2):613-30. PubMed ID: 12785564
[TBL] [Abstract][Full Text] [Related]
14. African-American patients with cancer Talking About Clinical Trials (TACT) with oncologists during consultations: evaluating the efficacy of tailored health messages in a randomised controlled trial-the TACT study protocol.
Brown RF; Davis R; Wilson Genderson M; Grant S; Cadet D; Lessard M; Alpert J; Ward J; Ginder G
BMJ Open; 2016 Dec; 6(12):e012864. PubMed ID: 27986738
[TBL] [Abstract][Full Text] [Related]
15. Minority Recruitment Trends in Phase III Prostate Cancer Clinical Trials (2003 to 2014): Progress and Critical Areas for Improvement.
Balakrishnan AS; Palmer NR; Fergus KB; Gaither TW; Baradaran N; Ndoye M; Breyer BN
J Urol; 2019 Feb; 201(2):259-267. PubMed ID: 30218761
[TBL] [Abstract][Full Text] [Related]
16. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study.
Advani AS; Atkeson B; Brown CL; Peterson BL; Fish L; Johnson JL; Gockerman JP; Gautier M
Cancer; 2003 Mar; 97(6):1499-506. PubMed ID: 12627515
[TBL] [Abstract][Full Text] [Related]
17. Associations between patient-provider communication and socio-cultural factors in prostate cancer patients: a cross-sectional evaluation of racial differences.
Song L; Weaver MA; Chen RC; Bensen JT; Fontham E; Mohler JL; Mishel M; Godley PA; Sleath B
Patient Educ Couns; 2014 Dec; 97(3):339-46. PubMed ID: 25224313
[TBL] [Abstract][Full Text] [Related]
18. Development and pilot test of a physician-focused cancer clinical trials communication training intervention.
Eggly S; Manning M; Senft N; Moore TF; Albrecht TL; Penner LA; Heath E; Carducci MA; Lansey DG; Hamel LM
PEC Innov; 2022 Dec; 1():100012. PubMed ID: 37364021
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
20. Assessing the effectiveness of a community health advisor plus screen to save educational intervention on stool-based testing adherence in an African American safety net clinic population: study protocol for a randomized pragmatic trial.
Luque JS; Matthew OO; Jackson DR; Vargas MA; Austin T; Ali A; Kiros GE; Harris CM; Tawk R; Gwede CK; Wallace K; Jean-Pierre P
Trials; 2022 Feb; 23(1):151. PubMed ID: 35168640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
